Innovation

Antibodies to West Nile virus infection

Sanford-Burnham Medical Research Institute
posted on 12/15/2009

Biologics 
                                            Infectious Diseases - Therapeutics


West Nile virus (WNV) is transmitted to humans from mosquito bites and can have varied effects ranging from asymptomatic infections to a neuroinvasive form called West Nile meningitis, which can be deadly. There is no specific treatment for WNV infection. The current invention provides antibodies for the treatment of WNV infection.

Lead Inventor
Alex Strongin, Ph.D.
Strongin lab homepage

Selected References
List of references via Pubmed

Patent Information

Full title: Binders to West Nile Virus Proteinase

Patent/Application #: 61/232,561

Date filed: 8-10-2009

Foreign filing: TBD

Burnham ID: 10-002

Status

Available for license


 











]]>


Innovation Details
 

File Number: 10-002/STRONGIN* 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Glenn Dourado, M. Sc., MBA at Sanford-Burnham Medical Research Institute for more information.

Request more info via email request more info
People

Case Manager:

Glenn Dourado, M. Sc., MBA Glenn Dourado, M. Sc., MBA

Innovations (166)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...